Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
The goal of this clinical trial is to culturally adapt an educational genetic counseling intervention to increase the uptake in genetic counseling and testing among African Americans at risk for heredity cancers. With the help of community stakeholders and clinical genetic professionals the investigators will: * adapt and refine a culturally relevant online educational genetic counseling program for at-risk African Americans * Test the effects of the educational program * collaborate with community leaders and…
Conditions studied
Female Breast Cancer, Prostate Cancer, Colorectal Carcinoma
About this study
The goal of this clinical trial is to culturally adapt an educational genetic counseling intervention to increase the uptake in genetic counseling and testing among African Americans at risk for heredity cancers. With the help of community stakeholders and clinical genetic professionals the investigators will: * adapt and refine a culturally relevant online educational genetic counseling program for at-risk African Americans * Test the effects of the educational program * collaborate with community leaders and clinical genetic professionals to translate study findings, develop a road map for dissemination to the community, and identify barriers to prepare for future trials. Participants from Detroit Research on Cancer Survivor group will be offered enrollment. Once consent is obtained, questionnaires will be completed before an online genetic counselling intervention immediately after, and at 3 months
Interventions
- Behavioral: Culturally adapted Online Genetic Counseling and Testing Information — Testing the effects of the educational intervention designed to increase the uptake of genetic counseling testing among at-risk African American survivors
Primary outcomes
- Uptake of genetic counseling and genetic testing (3 month follow Up)
Eligibility information
Study locations
- Karmanos Cancer Institute, Detroit, Michigan 48201 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.